Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Match Mel: Molecular Profiling and Matched Targeted Therapy in Advanced Melanoma
NCT02645149Phase 2Completed
- Sponsor
- Melanoma Institute Australia
- Start
- Nov 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib, ribociclib, ceritinib, pazopanib in melanoma, sponsored by Melanoma Institute Australia. Started Nov 2021; status: completed.
02
Drugs
trametinibribociclibceritinibpazopanib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02645149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02645149.